Black Rose Industries reported standalone FY26 PAT of ₹224.96 million, up 7.34% YoY, with Q4 PAT surging 113.62%.
Revenue declined 4.36% YoY to ₹3,258.38 million standalone, but EBITDA margins improved to 10.9% from 9.7% in FY25.
The company outlined Q1 FY27 outlook expecting subdued demand in distribution but stable manufacturing operations.
New product development includes PAM solid piloting and specialty amines project decision expected during FY27.